EUVIMEDEUVIMED entdecken
Crossref

Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia) Activity Using Reagent-/Platform-Specific Conversion Factors

Christian Irsara, Andrea Griesmacher, Bernhard Strasser, Axel Schlagenhauf, Christina Sorschag, Erich Wimmer, Florian Prüller, Janne Cadamuro, Johannes Radek, Josef Tomasits, Josef Seier, Peter Fraunberger und 5 weitere

Hämostaseologie · 01.08.2026 · 46 (04) · 283-292

DOI: 10.1055/a-2599-9908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.08.2026. Verfasst von Christian Irsara und 16 weiteren Autor:innen. Beteiligte Einrichtung: Central Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Polyethylene Glycols, Factor IX, Hemophilia B. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Austrian Society for Laboratory Medicine and Clinical Chemistry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonacog beta pegol (N9-GP) is a glycoPEGylated FIX replacement product with extended half-life for treatment of haemophilia B patients. Monitoring of N9-GP with clotting-based one-stage FIX assays is complicated by high variations, mainly due to reagent-specific interference with polyethylene glycol. In 11 distinct specialized coagulation laboratories in Austria, N9-GP spiked samples were measured in replicates in two distinct surveys, 3 years apart, using five different one-stage assay reagents and one chromogenic FIX assay. Regression analysis was used to investigate if back-calculation of N9-GP levels is feasible. We could demonstrate a linear relationship between the spiked N9-GP concentration and measured FIX activity levels for all examined assays, suggesting that N9-GP activity may be back-calculated using reagent-/platform-specific conversion factors. Within-laboratory variation after 3 years was acceptable in most, but not all, laboratories. We demonstrate that back-calculation of N9-GP activity levels may be possible when using one-stage FIX assays. However, we recommend that every laboratory ascertain its own conversion factor. When measuring real patient samples, we encourage simultaneous measurement of N9-GP spiked control material with known concentrations to ensure the validity of the current back-calculation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyethylene GlycolsFactor IXHemophilia BHumansReproducibility of ResultsBlood Coagulation TestsRecombinant Proteins

Substanzen

Polyethylene GlycolsFactor IXnonacog beta pegolRecombinant Proteins

Autor:innen und Institutionen

  • Central Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital of Innsbruck, Innsbruck, Austria.
  • Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC), Vienna, Austria.
  • Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests (ÖQUASTA), Vienna, Austria.
  • Institute for Medical and Chemical Laboratory Diagnostics, Hospital Wels-Grieskirchen, Wels, Austria.
  • Department of Pediatrics and Adolescent Medicine, Division of General Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Institute of Laboratory Medicine and Microbiology, Hospital Klagenfurt, Klagenfurt, Austria.

Förderung

  • Austrian Society for Laboratory Medicine and Clinical Chemistry

Zitieren

APA

Irsara, C., Griesmacher, A., Strasser, B., Schlagenhauf, A., Sorschag, C., Wimmer, E., Prüller, F., Cadamuro, J., Radek, J., Tomasits, J., Seier, J., Fraunberger, P., Quehenberger, P., Lirk, G., Sussitz-Rack, S., Mink, S., & Haushofer, A. (2026). Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia) Activity Using Reagent-/Platform-Specific Conversion Factors. Hämostaseologie, 46(04), 283-292. https://doi.org/10.1055/a-2599-9908

Vancouver

Irsara C, Griesmacher A, Strasser B, Schlagenhauf A, Sorschag C, Wimmer E, et al. Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia) Activity Using Reagent-/Platform-Specific Conversion Factors. Hämostaseologie. 2026;46(04):283-292. doi:10.1055/a-2599-9908

BibTeX
@article{Irsara2026,
  author = {Irsara, Christian and Griesmacher, Andrea and Strasser, Bernhard and Schlagenhauf, Axel and Sorschag, Christina and Wimmer, Erich and Prüller, Florian and Cadamuro, Janne and Radek, Johannes and Tomasits, Josef and Seier, Josef and Fraunberger, Peter and Quehenberger, Peter and Lirk, Gerald and Sussitz-Rack, Sabine and Mink, Sylvia and Haushofer, Alexander},
  title = {Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia) Activity Using Reagent-/Platform-Specific Conversion Factors},
  journal = {Hämostaseologie},
  year = {2026},
  volume = {46},
  number = {04},
  pages = {283--292},
  doi = {10.1055/a-2599-9908}
}
Kostenlos starten →